2022 National Cancer Patient Experience Survey
The latest results from the 2022 National Cancer Patient Experience [...]
The latest results from the 2022 National Cancer Patient Experience [...]
A recent study compared the success of robot-assisted partial nephrectomy [...]
A new multi-cancer early detection blood test could speed up [...]
At the start of July, one of the Action Kidney [...]
Sharon Deveson Kell was invited by Cancer52 to represent the [...]
Sharon Deveson Kell represented the kidney cancer community at the [...]
Immunotherapy combinations are becoming the standard treatment after surgery for [...]
TIVO-3 was a phase 3 clinical trial that compared tivozanib, [...]